Abstract
Obesity is a worldwide issue that is progressively worsening. It can result in significant co-morbidities, including type 2 diabetes, cardiovascular disease, and obesity-related cancers. Current treatment options for obesity have several limitations, and the connection between obesity and cancer development is not well comprehended. We examine the current state and future prospects of obesity therapy, with a focus on the potential application of nanomedicine. The presentation emphasizes the necessity for further research in this field and how developments in cancer therapy using nanomedicines could be applied for the treatment of obesity, thereby providing a safe and effective treatment with reduced side-effects for those patients.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Review of Clinical Pharmacology and Pharmacokinetics - International Edition
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.